Airways inflammation in chronic bronchitis: The effects of smoking and α1-antitrypsin deficiency

European Respiratory Journal

Volumn 15, Issue 5, 2000, Pages 886-890

  Hill, A T ^a   Bayley, D L ^a   Campbell, E J ^b   Hill, S L ^a   Stockley, R A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

1 antitrypsin; Bronchial disease; Inflammation; Smoking

Indexed keywords

ALPHA 1 ANTITRYPSIN; CIGARETTE SMOKE; ELASTASE INHIBITOR; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; MYELOPEROXIDASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HUMAN; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPUTUM;

ADULT; AGED; AIRWAY OBSTRUCTION; ALPHA 1-ANTITRYPSIN DEFICIENCY; BRONCHITIS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING; SPUTUM;

EID: 0034126045     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15e12.x     Document Type: Article

References (35)

1. Badham C. Observations on the inflammatory affections of the mucous membrane of the bronchiae. London, UK, Callow, 1808.
2. Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-365.
3. Keatings VM, Barnes PJ. Comparison of inflammatory cytokines in chronic obstructive pulmonary disease, asthma and controls. Eur Respir Rev 1997; 7: 146-150.
4. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158: 1277-1285.
5. Stanescu D, Sanna A, Veriter C, et al Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
6. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128: 833-838.
7. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 155: 1770-1776.
8. Snider GL, Lucey EC, Christensen TG, et al. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis 1984; 129: 155-160.
9. Amitani R, Wilson R, Rutman A, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 1991; 4: 26-32.
10. Smallman LA, Hill SL, Stockley RA. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax 1984; 39: 663-667.
11. Snider GL, Stone PJ, Lucey EC, et al. Eglin C, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia. Am Rev Respir Dis 1985; 132: 1155-1161.
12. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990; 85: 682-689.
13. Solomon A. Possible role of PMN proteinases in immunoglobulin degradation and amyloid formation. Baltimore, USA, Urban and Schwarzenberg, 1978.
14. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86: 300-308.
15. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152: 1316-1320.
16. Morrison HM, Kramps JA, Afford SC, Burnett D, Dijkman JH, Stockley RA. Elastase inhibitors in sputum from bronchitic patients with and without alpha-1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase. Clin Sci 1987; 73: 19-28.
17. Gadek JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981; 68: 889-898.
18. Lieberman J, Gaidulis L, Garoutte B, Mittman C. Identification and characteristics of the common alpha-1-antitrypsin phenotypes. Chest 1972; 62: 557-564.
19. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138: 327-336.
20. Eriksson S. Studies in alpha-1-antitrypsin deficiency. Acta Med Scand 1965; 432: 1-85.
21. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965; 1: 775-779.
22. Pye A, Stockley RA, Hill SL. Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol 1995; 48: 719-724.
23. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153: 616-621.
24. Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999; 160: 893-898.
25. Stockley RA. Measurement of soluble proteins in lung secretions. Thorax 1984; 39: 241-247.
26. British Thoracic Society. Guidelines for the measurement of respiratory function. Respir Med 1994; 88: 165-194.
27. Hill A, Bayley D, Crooks S, Hill S, Campbell E, Stockley R. The relationship of bacteria to bronchial inflammation. Eur Respir J 1998; 12: Suppl. 28, 230s.
28. Mikami M, Llewellyn-Jones CG, Bayley D, Hill SL, Stockley RA. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998; 157: 723-728.
29. Stockley RA, Burnett D. Alpha-1-antitrypsin and leukocyte elastase in infected and noninfected sputum. Am Rev Respir Dis 1979; 120: 1081-1086.
30. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264: L413-L418.
31. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 1996; 153: 1072-1079.
32. Meyer KC, Rosenthal NS, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998; 104: 169-181.
33. 4 by alveolar macrophages. J Clin Invest 1991; 88: 891-897.
34. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11: 733-741.
35. Peterson MW, Walter ME, Nygaard SD. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Biol 1995; 13: 719-727.